Krishna Athmakuri: Evaluating Left Atrial Appendage Occlusion Against Oral Anticoagulation
Krishna Athmakuri, Research Trainee at Mayo Clinic, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in EP Europace, adding:
“I am incredibly honoured to share that our Bayesian meta-analysis comparing left atrial appendage occlusion (LAAO) versus oral anticoagulation (OAC) has been published in the prestigious EP Europace.
Our analysis revisits the non-inferiority conclusions of the pivotal LAAO trials through a Bayesian framework. The findings suggest that the available evidence may not support the claimed non-inferiority of LAAO to OAC as confidently as previously believed.
The posterior probabilities of non-inferiority revealed through a Bayesian framework highlight this uncertainity.
This honour is surpassed only by the fact that our paper was cited and discussed in an editorial published in EP Europace. Having our work recognised on such a prestigious platform is both immensely gratifying and deeply humbling.
I am immensely grateful to my mentors Komandoor Srivathsan, Hari Chaliki, co-authors Shreyas Raghavan Nandyal, Hrushikesh Reddy, Saketh Vinjamuri, Shanmukh Lingamsetty, Anushka Mahajan, Muqaddas Hussain for their guidance, support, and contributions throughout this project.”
Title: Comparative evaluation of left atrial appendage occlusion and oral anticoagulation
Authors: Krishna Saketh Athmakuri , Shreyas Raghavan Nandyal , Hrushikesh Reddy Pamreddy , Saketh Vinjamuri , Shanmukh S P Lingamsetty , Anushka Vishwas Mahajan , Muqaddas Hussain , Hari P Chaliki , Komandoor Srivathsan
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI